Articles On Immutep (ASX:IMM)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Immutep sees first patient dosed in 4th arm of cancer trial
06 Jun 2019 - Biotech company Immutep (ASX:IMM) reports that the first patient in the INSIGHT-004 Phase I clinical trial has received the first dose of treatment in Germany. |
FNN | IMM | 5 years ago |